Skip to NavigationSkip to content

News

After more than a month of uncertainty, Takeda has finally confirmed it has managed to successfully acquire Shire, agreeing on a valuation of £46...
Check out the week's ten most popular articles on Pharmafile.com now!
The city of Los Angeles has levied legal action against a number of pharmaceutical firms for their role in advancing the ongoing US opioid crisis,...
Mallinckrodt paid $80 million, with a further $345 million dependent on milestones, to acquire InfaCare in the hope that the latter’s treatment for...
Our latest free webinar reflects on how best to implement the revised GVP module, in regards to risk management during the life-cycle of a medicine.
Bristol-Myers Squibb has extended its existing collaboration with Flatiron Health by three years and expanded the efforts both will be making in...
A new study by scientists in Australia has put forward an explanation for why current approaches have failed to produce progress in dementia and...
Promising new findings have been revealed in the efficacy of MDMA in treating post-traumatic stress disorder (PTSD).
Barcelona will play host to Veeva R&D Summit, Europe next month. This annual conference will be the place for more than 350 European R...
In Novartis’ recently released Q1 results, which largely beat analysts’ estimates, Sandoz was a black spot on its record – with sales of the generics...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches